Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Cortisol and Oxytocin Could Predict Covert Aggression in Some Psychotic Patients

View through CrossRef
Background: The covert or indirect type of aggression has a risk of converting in violent acts and, considering that, it is very important to identify it in order to apply effective preventive measures. In cases of psychotic patients, the risk of becoming violent is harder to predict, as even neuter stimuli may be perceived as threat and trigger aggression. Treating all the psychiatric patients as potential aggressive subjects is not the best preventive measure as only a few of them are aggressive and this measure may further enhance the stigma on mentally ill patients. There is a current need for better understanding of covert aggression and to find objective measures, such as biological markers, that could be indicative of potential violent behavior. In this work, we try to investigate the role of cortisol and oxytocin as potential biomarkers of aggression in patients with psychosis. Material and Methods: We analyzed the level of peripheral oxytocin (pg/mL) and cortisol level (ng/mL) in 28 psychotic patients (they were not on psychotropic treatment at the moment of admission and those with substance abuse or personality disorder were excluded from the study) and correlated it with the intensity of aggression reported by the patient (overt and covert type) using the Overt Covert Aggression Inventory and the level of observed aggression of the patient in the past 7 days (rated by the health care provider) using the Modified Overt Aggression Scale. Results: We found that psychotic patients with a higher level of covert aggression had a lower level of cortisol (61.05 ± 8.04 ng/mL vs. 216.33 ± 12.6.9 ng/mL, p ˂ 0.01) and a higher level of oxytocin (102.87 ± 39.26 vs. 70.01 ± 25.07, p = 0.01) when compared with patients with a lower level of covert aggression. Furthermore, we observed significant negative correlation between cortisol and covert aggression (r = −0.676, p < 0.001) and between oxytocin and covert type of aggression (r = 0.382, p = 0.04). Moreover, we found that a lower level of cortisol together with a higher level of oxytocin are significant predictors of a style of internalized manifestation of aggression, with the predictive model explaining 55% of the variant of the internalized manifestation of aggression (F (2.25) = 17.6, p < 0.001, β = 0.35, R2 = 55.2). We did not find significant correlations between cortisol and overt aggression, and neither between oxytocin and overt aggression. Positive correlations were also found between the overt type of self-reported aggression and overt aggression reported by the rater (r = 0.459, p = 0.01). Conclusions: The importance of a predictive model in understanding covert aggression is imperative and the results of our study show that oxytocin and cortisol warrant to be further investigated in establishing a definitive predictive model for covert aggression.
Title: Cortisol and Oxytocin Could Predict Covert Aggression in Some Psychotic Patients
Description:
Background: The covert or indirect type of aggression has a risk of converting in violent acts and, considering that, it is very important to identify it in order to apply effective preventive measures.
In cases of psychotic patients, the risk of becoming violent is harder to predict, as even neuter stimuli may be perceived as threat and trigger aggression.
Treating all the psychiatric patients as potential aggressive subjects is not the best preventive measure as only a few of them are aggressive and this measure may further enhance the stigma on mentally ill patients.
There is a current need for better understanding of covert aggression and to find objective measures, such as biological markers, that could be indicative of potential violent behavior.
In this work, we try to investigate the role of cortisol and oxytocin as potential biomarkers of aggression in patients with psychosis.
Material and Methods: We analyzed the level of peripheral oxytocin (pg/mL) and cortisol level (ng/mL) in 28 psychotic patients (they were not on psychotropic treatment at the moment of admission and those with substance abuse or personality disorder were excluded from the study) and correlated it with the intensity of aggression reported by the patient (overt and covert type) using the Overt Covert Aggression Inventory and the level of observed aggression of the patient in the past 7 days (rated by the health care provider) using the Modified Overt Aggression Scale.
Results: We found that psychotic patients with a higher level of covert aggression had a lower level of cortisol (61.
05 ± 8.
04 ng/mL vs.
216.
33 ± 12.
6.
9 ng/mL, p ˂ 0.
01) and a higher level of oxytocin (102.
87 ± 39.
26 vs.
70.
01 ± 25.
07, p = 0.
01) when compared with patients with a lower level of covert aggression.
Furthermore, we observed significant negative correlation between cortisol and covert aggression (r = −0.
676, p < 0.
001) and between oxytocin and covert type of aggression (r = 0.
382, p = 0.
04).
Moreover, we found that a lower level of cortisol together with a higher level of oxytocin are significant predictors of a style of internalized manifestation of aggression, with the predictive model explaining 55% of the variant of the internalized manifestation of aggression (F (2.
25) = 17.
6, p < 0.
001, β = 0.
35, R2 = 55.
2).
We did not find significant correlations between cortisol and overt aggression, and neither between oxytocin and overt aggression.
Positive correlations were also found between the overt type of self-reported aggression and overt aggression reported by the rater (r = 0.
459, p = 0.
01).
Conclusions: The importance of a predictive model in understanding covert aggression is imperative and the results of our study show that oxytocin and cortisol warrant to be further investigated in establishing a definitive predictive model for covert aggression.

Related Results

Quiet wakefulness: The influence of intraperitoneal and intranasal oxytocin on sleep-wake behaviour and neurophysiology in rats
Quiet wakefulness: The influence of intraperitoneal and intranasal oxytocin on sleep-wake behaviour and neurophysiology in rats
AbstractIntroductionExogenous administration of the neuropeptide oxytocin exerts diverse effects on various neurobehavioural processes, including sleep and wakefulness. Since oxyto...
Gender Differences in Children's Expression and Control of Fantasy Aggression
Gender Differences in Children's Expression and Control of Fantasy Aggression
The purpose of this study was to examine: 1) possible gender differences in children's expression of aggression in story sequences; 2) possible gender differences in children's exp...
Physiology of invertebrate oxytocin and vasopressin neuropeptides
Physiology of invertebrate oxytocin and vasopressin neuropeptides
New findings What is the topic of this review?This article describes the discovery and function of invertebrate oxytocin and vasopressin neuropeptides. What advances does it highli...
Prevention of prolonged labour in term nulliparas with oxytocin alone versus with oxytocin and an antispasmodic
Prevention of prolonged labour in term nulliparas with oxytocin alone versus with oxytocin and an antispasmodic
Background: Poor progress of labour is a common problem with nulliparous deliveries. It occurs when the cervical dilatation rate in the active phase of the first stage of labour is...
Oxytocin determination in steroid producing tissues and in vitro production in ovarian follicles
Oxytocin determination in steroid producing tissues and in vitro production in ovarian follicles
Abstract Immunoreactive oxytocin was measured in ovaries (corpus luteum and follicular fluid) and adrenals of cows, and in testes, seminal vesicles, prostate gland and adrenals of ...
Comparative Study between Oxytocin and Carbetocin for the prevention of Primary Postpartum Hemorrhage following Caesarean Section
Comparative Study between Oxytocin and Carbetocin for the prevention of Primary Postpartum Hemorrhage following Caesarean Section
Background & objective: Of the many pharmacological options for the management of postpartum hemorrhage, oxytocin is the first line of treatment. The newer drug carbetocin is g...

Back to Top